Tag: Patients
ReWalk Raises $5M for its ReStore Exosuit for Stroke Victims
Standing Tall
ReWalk Robotics (NASDAQ: RWLK) recently received an approval for its ReStore exoskeleton system, indicated for rehabilitation of stroke victims, from the FDA. The company...
LogicBio Therapeutics: Potential breakthrough in the Treatment of Methylmalonic Acidemia (MMA).
LogicBio Therapeutics (NASDAQ: LOGC), a gene-editing company that uses its GeneRide technology platform to develop solutions for rare diseases in pediatric patients was recently...
Zolmitriptan Derivatives and Novel Drug Delivery Systems Aim to treat Acute...
Migraine is a genetic predisposition to moderate-to-severe headaches caused due to stress, physiological factors such as lack of sleep, hunger and environmental triggers such...
PhaseBio poised to make rapid strides in the Anti-Coagulant Reversal Market
PhaseBio’s (NASDAQ: PHAS), PB2452 is the new drug on the block, which has received a breakthrough therapy status from the FDA in April 2019....
We are looking for talented interns to learn and help investors find valuable companies.